Another week, another drug industry-funded consultant attempting to divert attention away from the high and rising costs of prescription drugs by attacking the 340B drug pricing program.
Hospitals and health systems are continuously striving to reduce costs and improve the efficiency of care. It is useful to consider the impact of measuring the “total cost of care” on hospitals and health systems, as well as contemplate what steps health care leaders need to take.
